COVID-19 nAbs (Aegis Life)

N/A

Report date: 2022/01/05 10:28:42

Base Information

Drug NameCOVID-19 nAbs (Aegis Life)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionDNA modulatorsRNA modulators
TargetsDNARibonucleic Acid
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAegis Life Inc
China Registration ClassN/A

Develop Information

Active CompaniesAegis Life Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A